DCF — MARY IMOGENE BASSETT HOSPITAL
Enterprise Value: $-467.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-467.9M
Enterprise Value
$-156.5M
PV of Cash Flows
$-311.4M
PV of Terminal Value
$-501.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $545.0M | $-24.5M | -5.0% | $-47.6M | $-43.3M |
| Year 2 | $561.3M | $-19.6M | -4.0% | $-43.4M | $-35.9M |
| Year 3 | $578.2M | $-14.5M | -3.0% | $-38.9M | $-29.2M |
| Year 4 | $595.5M | $-11.9M | -2.0% | $-37.1M | $-25.4M |
| Year 5 | $613.4M | $-10.7M | -2.0% | $-36.7M | $-22.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-467.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$529.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000000566993136
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5